Literature DB >> 15344916

17Beta-oestradiol modulates glucocorticoid, neural and behavioural adaptations to repeated restraint stress in female rats.

P Lunga1, J Herbert.   

Abstract

Sex steroids have a role in modulating responses that extends beyond reproduction. The current study investigated the influence of the sex steroid 17beta-oestradiol on hypothalamic-pituitary-adrenal (HPA) and behavioural responses to acute or repeated restraint stress. Ovariectomized rats treated with 17beta-oestradiol or peanut oil via a subcutaneous silastic capsule were subjected to daily handling (non stressed), acute (single, 1 h) or daily (10 days, 1 h/day) restraint stress. Blood collected at the end of stress revealed that 17beta-oestradiol treatment augmented the corticosterone response to acute restraint. After daily exposure to restraint, the corticosterone response was noticeably diminished in untreated females but 17beta-oestradiol-treated rats still showed an exaggerated response compared to castrated, untreated females. Brain tissue collected 3 h after the end of restraint was probed using isotopic in situ hybridization for corticotropin-releasing factor (CRF) and vasopressin gene expression in the paraventricular nucleus (PVN) of the hypothalamus. 17beta-oestradiol treatment at the higher dose (120 microg/ml) decreased basal CRF mRNA. Stress caused an increase in CRF mRNA expression in 17beta-oestradiol-treated rats but not in the vehicle group. Repeated restraint stress caused an increase in PVN parvocellular vasopressin gene expression, which was more pronounced in 17beta-oestradiol-replaced rats. Animals were exposed to the elevated plus maze for 5 min as a test for anxiety. Non-stressed control rats with or without 17beta-oestradiol replacement spent the same percentage amount of time exploring the open arms of the maze. Previous exposure to acute restraint stress caused a marked reduction in the time spent exploring the open arms, indicating an increase in anxiety levels in these rats; this effect was observed in both vehicle and 17beta-oestradiol-treated rats. After repeated restraint stress, 17beta-oestradiol-replaced rats spent as much time exploring the open arms of the maze as controls, indicating adaptation. By contrast, nonreplaced rats were still showing a significant reduction in open arm exploration after repeated restraint. The present study presents novel data showing that the HPA axis remains reactive to repeated stress in 17beta-oestradiol-treated ovariectomized rats, but stress-induced anxiety behaviour is reduced.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15344916      PMCID: PMC2651633          DOI: 10.1111/j.1365-2826.2004.01234.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  61 in total

1.  Sex-dependent effects of inescapable shock administration on shuttlebox-escape performance and elevated plus-maze behavior.

Authors:  H L Steenbergen; R P Heinsbroek; A Van Hest; N E Van de Poll
Journal:  Physiol Behav       Date:  1990-10

2.  Sex differences in animal tests of anxiety.

Authors:  A L Johnston; S E File
Journal:  Physiol Behav       Date:  1991-02

3.  Adaptation of female rats to stress: shift to male pattern by inhibition of corticosterone synthesis.

Authors:  D J Haleem; G Kennett; G Curzon
Journal:  Brain Res       Date:  1988-08-23       Impact factor: 3.252

4.  Corticotropin releasing hormone mRNA is elevated on the afternoon of proestrus in the parvocellular paraventricular nuclei of the female rat.

Authors:  H C Bohler; R T Zoeller; J C King; B S Rubin; R Weber; G R Merriam
Journal:  Brain Res Mol Brain Res       Date:  1990-08

5.  Sex differences in adrenocortical structure and function. XXVIII. ACTH and corticosterone in intact, gonadectomised and gonadal hormone replaced rats.

Authors:  B Leśniewska; M Nowak; L K Malendowicz
Journal:  Horm Metab Res       Date:  1990-07       Impact factor: 2.936

6.  Sex differences in adrenocortical structure and function. XXVII. The effect of ether stress on ACTH and corticosterone in intact, gonadectomized, and testosterone- or estradiol-replaced rats.

Authors:  B Leśniewska; B Miśkowiak; M Nowak; L K Malendowicz
Journal:  Res Exp Med (Berl)       Date:  1990

7.  Repeated stress-induced activation of corticotropin-releasing factor neurons enhances vasopressin stores and colocalization with corticotropin-releasing factor in the median eminence of rats.

Authors:  D C de Goeij; R Kvetnansky; M H Whitnall; D Jezova; F Berkenbosch; F J Tilders
Journal:  Neuroendocrinology       Date:  1991-02       Impact factor: 4.914

8.  Does estradiol treatment normalize the hypothalamic-pituitary-adrenal axis in streptozotocin-induced ovariectomized diabetic female rats?

Authors:  K E Elkind-Hirsch; C T Valdes; D G Rogers
Journal:  Horm Metab Res       Date:  1991-10       Impact factor: 2.936

9.  Variations in the hypothalamic-pituitary-adrenal response to stress during the estrous cycle in the rat.

Authors:  V Viau; M J Meaney
Journal:  Endocrinology       Date:  1991-11       Impact factor: 4.736

10.  Hormonal regulation of type II glucocorticoid receptor messenger ribonucleic acid in rat brain.

Authors:  A Peiffer; B Lapointe; N Barden
Journal:  Endocrinology       Date:  1991-10       Impact factor: 4.736

View more
  21 in total

Review 1.  Sex differences in psychopathology: of gonads, adrenals and mental illness.

Authors:  Matia B Solomon; James P Herman
Journal:  Physiol Behav       Date:  2009-03-09

2.  Habituation of hypothalamic-pituitary-adrenocortical axis hormones to repeated homotypic stress and subsequent heterotypic stressor exposure in male and female rats.

Authors:  Jessica A Babb; Cher V Masini; Heidi E W Day; Serge Campeau
Journal:  Stress       Date:  2014-04-10       Impact factor: 3.493

3.  Gonadal steroid modulation of the limbic-hypothalamic- pituitary-adrenal (LHPA) axis is influenced by social status in female rhesus monkeys.

Authors:  Mark E Wilson; Ariadne Legendre; Karen Pazol; Jeffrey Fisher; Kathy Chikazawa
Journal:  Endocrine       Date:  2005-03       Impact factor: 3.633

4.  Corticotropin-releasing factor modulation of forebrain GABAergic transmission has a pivotal role in the expression of anabolic steroid-induced anxiety in the female mouse.

Authors:  Joseph G Oberlander; Leslie P Henderson
Journal:  Neuropsychopharmacology       Date:  2012-02-01       Impact factor: 7.853

5.  Stress induces equivalent remodeling of hippocampal spine synapses in a simulated postpartum environment and in a female rat model of major depression.

Authors:  Judith Baka; Eszter Csakvari; Orsolya Huzian; Nikoletta Dobos; Laszlo Siklos; Csaba Leranth; Neil J MacLusky; Ronald S Duman; Tibor Hajszan
Journal:  Neuroscience       Date:  2016-12-22       Impact factor: 3.590

6.  Androgens Drive Sex Biases in Hypothalamic Corticotropin-Releasing Hormone Gene Expression After Adrenalectomy of Mice.

Authors:  Ashley L Heck; Robert J Handa
Journal:  Endocrinology       Date:  2019-07-01       Impact factor: 4.736

7.  CRH receptor antagonism reverses the effect of social subordination upon central GABAA receptor binding in estradiol-treated ovariectomized female rhesus monkeys.

Authors:  V Michopoulos; M Embree; K Reding; M M Sanchez; D Toufexis; J R Votaw; R J Voll; M M Goodman; J Rivier; M E Wilson; S L Berga
Journal:  Neuroscience       Date:  2013-07-12       Impact factor: 3.590

Review 8.  Habituation to repeated stress: get used to it.

Authors:  Nicola Grissom; Seema Bhatnagar
Journal:  Neurobiol Learn Mem       Date:  2008-08-19       Impact factor: 2.877

Review 9.  Sex differences in stress-related psychiatric disorders: neurobiological perspectives.

Authors:  Debra A Bangasser; Rita J Valentino
Journal:  Front Neuroendocrinol       Date:  2014-04-12       Impact factor: 8.606

10.  Female crucian carp, Carassius carassius, lose predator avoidance behavior when getting ready to mate.

Authors:  Stine Lastein; Erik Höglund; Ian Mayer; Oyvind Overli; Kjell B Døving
Journal:  J Chem Ecol       Date:  2008-10-21       Impact factor: 2.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.